Showing results (931-940 of 1,137) with videos related to

Sort By:
Pageof 114
Tuberculosis (Edinburgh, Scotland)|October 21, 2017
Single nucleotide polymorphisms in efflux pumps genes in extensively drug resistant Mycobacterium tuberculosis isolates from PakistanAkbar Kanji, Rumina Hasan, Asho Ali, et al.
Urologic Oncology|December 17, 2015
Characterization of clear cell renal cell carcinoma by gene expression profilingBryan J Thibodeau, Matthew Fulton, Laura E Fortier, et al.
Medicine|June 27, 2020
Myxedema psychosis: A protocol for a systematic review and a pooled analysisMouhand F H Mohamed, Timo Siepmann, Salah Suwileh, et al.
Diagnostics (Basel, Switzerland)|May 23, 2020
Clinical Validation of Integrated Point-of-Care Devices for the Management of Non-Communicable DiseasesK V Giriraja, Suman Govindaraj, H P Chandrakumar, et al.
GMS Hygiene and Infection Control|December 24, 2025
Spinal tuberculosis treatment duration: Correlating MRI findings with therapeutic outcomesMahesh Shinde, Sangramsingh Dixit, Mihir Patel, et al.
RSC Advances|March 19, 2025
Corey-Fuchs reaction enabled synthesis of natural products: a reviewRabia Ashraf, Ameer Fawad Zahoor, Samreen Gul Khan, et al.
Bioorganic & Medicinal Chemistry|April 7, 2012
Synthesis, biological evaluation, and molecular docking studies of benzyl, alkyl and glycosyl [2-(arylamino)-4,4-dimethyl-6-oxo-cyclohex-1-ene]carbodithioates, as potential immunomodulatory and immunosuppressive agentsEl Sayed H El Ashry, Mohammad R Amer, Omer M Abdalla, et al.
Clinical Case Reports|January 9, 2026
Delayed Aggressive Local Recurrence of Chondroblastic Osteosarcoma 3 Years After an Excellent Pathological Response: A Case ReportAbdul Hannan, Bilal Aslam, Natasha Hastings, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 16, 2026
HLA-B*44 Alleles and HLA-DQA1*03:01 as Genetic Risk Factors for Drug-Induced Liver Injury due to FluoroquinolonesPaola Nicoletti, M Isabel Lucena, Raul J Andrade, et al.
Cancers|November 27, 2021
Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age ReportingThejus Jayakrishnan, Sonikpreet Aulakh, Mizba Baksh, et al.
Pageof 114